jab

A HIGHER ‘golden dose’ of Wegovy than is currently approved is safe and could be more effective – helping patients lose nearly a fifth of their body weight.

The once-weekly injection containing the semaglutide – also the active ingredient in diabetes jab Ozempic – is prescribed on the NHS at a maximum dose of 2.4mg.

1

Now, two major studies show that tripling doses to 7.2mg can trigger significant weight loss, without bringing on more side effects or risking patient safety.

The findings, published in The Lancet Diabetes & Endocrinology journal, suggest a higher dose of semaglutide could be an option for people with obesity – as well as type 2 diabetes – who haven’t lost enough weight on standard doses.

“Once-weekly subcutaneous semaglutide 2.4 mg is approved for weight management in people with obesity and related complications,” researchers said.

“However, some individuals do not reach their therapeutic goals with this dose.

“We aimed to test the efficacy and safety of a higher dose of semaglutide in people with obesity.”

Researchers investigated whether 7.2mg semaglutide injections could provide patients with “further benefits” and boost fat loss for people whose weight had plateaued “without jeopardising safety or significantly increasing the risk of adverse events”.

The two trials involved more than 2,000 adults with obesity, some of whom also had diabetes.

They were conducted across 95 hospitals, specialist clinics, and medical centres in 11 countries, including Canada, Germany, Greece, Norway and the US.

Researchers randomly assigned participants the 7.2mg dose, the 2.4mg dose, or placebo injections.

All participants received advice on improving diet and increasing exercise.

After 72 weeks, people without diabetes given the higher dose lost an average of 18.7 per cent of their body weight.

Those on the standard dose 15.6 per cent of their weight and those on placebo injections lost just 3.9 per cent.

Almost half of those on the higher dose lost at least 20 per cent of their body weight, while nearly a third shed 25 per cent or more.

This rivals the average weight lost with competitor jab Mounjaro, known as the ‘King Kong’ of weight loss injections.

Participants on the higher dose also saw their waists shrink and reported improvements in their blood pressure, blood sugar, and cholesterol levels – all key factors in reducing obesity-related health risks.

As for obese adults with type 2 diabetes, the 7.2mg dose caused them to lose 13 per cent of their weight.

Those on 2.4mg lost 10 per cent of their body weight on average, while placebo-users lost 4 per cent.

Both trials showed the higher semaglutide dose to be safe and generally well tolerated, though people taking 7.2mg did report more side effects.

“Serious adverse events” were reported by 68 of 1004 participants receiving the 7.2mg dose of semaglutide – about 7 per cent – researchers said.

Meanwhile, 22 of 201 taking 2.4mg reported side effects – about 11 per cent – and 11 of 201 receiving placebo injections, researchers said.

Nausea and diarrhoea, and some sensory symptoms like tingling, were the most common.

However, most side effects were manageable and resolved over time, researchers said.

One in 20 patients taking the higher dose stopped treatment because of side effects, similar to the standard jab.

Study authors concluded: “Semaglutide 7.2 mg was superior to placebo and semaglutide 2.4 mg in reducing bodyweight, including reaching reductions of 20 per cent or greater and 25 per cent or greater over 72 weeks.

The higher dose was “well tolerated and provided additional clinically meaningful weight loss compared with 2.4 mg, suggesting that higher doses could help patients who do not achieve sufficient weight loss with the currently approved dose”, they added.

But Professor Alex Miras, an obesity expert at Imperial College London, was more hesitant in touting the benefits of the 7.2mg dose.

He told the Daily Mail: “Tripling the dose only gives a marginal extra benefit, but the dose increase is massive.

“Going from 2.4mg to 7.2mg is a very big jump. I’m concerned many patients won’t tolerate such a high dose.

“In clinical practice people already struggle at 2.4mg.

“Even if 7.2mg is approved, I suspect uptake will be low because of cost and side-effects – the top dose is already expensive.”

It comes as many Brits taking weight loss jabs privately are priced out of paying for Mounjaro – after manufacturer Eli Lilly hiked up prices.

The highest dose was set to rise from £122 to £330 a month – an increase of 170 per cent – from September 1.

It was later reported that some pharmacies would be able to offer the jabs at a discount, saving patients £83 on the cost of the maximum dose.

But the price rise has still made Mounjaro unaffordable for many – leading Brits to switch to cheaper Wegovy or give up the jabs altogether.

In the UK, fewer than 200,000 people are thought to be accessing weight-loss jabs through the NHS, but over 1.4 million are estimated to be using them privately, according to the health think-tank the King’s Fund.

Meanwhile, jabs such as Ozempic, Wegovy and Mounjaro have been connected to 24 deaths in the 21 weeks since January, The Sun revealed.

ALL medications, including prescription drugs, over-the-counter medicines, and even herbal remedies, have the potential to cause side effects.

But experts have warned weight loss jab users to pay real attention to any side effects they experience, as they could actually be signalling deadly cancer, as Dawn Clegg tragically found out.

5

5

5

The 51-year-old, from Morecambe, Lancashire, had been using Mounjaro to treat her diabetes, but in March this year, she began suffering from chest pain, which she initially put down to a side effect of the jabs.

When the pain persisted, she headed to A&E before doctors made a shocking discovery.

After undergoing several X-rays, doctors spotted shadows on her lungs, kidneys and breast, and she was diagnosed with soft-tissue cancer, known as sarcoma.

Dawn was then given the life-shattering news that she had less than a year to live.

Her heartbroken husband, Arron Clegg, 51, is planning to hold a “living wake” in November to celebrate the life of his wife.

He said: “We were devastated on hearing news of cancer in these areas – there is no cure and she is now terminal.”

Weight loss expert at The Lagom Clinic, Dr Jack Ogden, said he has also been made aware of a fat jab user mistaking symptoms of cancer for side effects, though they weren’t linked to the clinic.

He tells Sun Health: “As a clinician, hearing about cases like this is always sobering. It reinforces how easy it is for both patients and healthcare professionals to attribute symptoms to the most obvious cause.

“In this case, weight loss injections, when something more serious may be underlying.”

The fat jab user, a 52-year-old who remains anonymous, began experiencing persistent fatigue, feeling full quickly, and mild nausea while on a GLP-1 weight loss injection.

They initially assumed these symptoms were routine side effects, but they persisted beyond the expected two to three-week adjustment period.

Further investigation by their GP revealed a diagnosis of stage two stomach cancer – which isn’t very common in the UK but can be deadly.

When detected early, stomach cancer has a high chance of being cured.

But it’s often diagnosed at a more advanced stage, which makes it harder to treat and means survival rates can be low.

Dr Ogden said: “It’s important to monitor persistent symptoms, keep a log of side effects, and seek prompt medical advice if anything unusual arises.”

So what cancer symptoms could people mistake for the side effects of fat jabs?

Here, a team of experts offer their life-saving advice…

THE SYMPTOMS YOU MUST NOT IGNORE

5

THERE are more than 200 different types of cancer, and they all have different signs and symptoms.

While some affect specific areas of the body, symptoms can be more general and similar to those caused by less serious conditions or medication side effects.

Superintendent pharmacist at pharmica.co.uk, Ana Carolina Goncalves, said symptoms such as persistent indigestion, heartburn and abdominal pain are potential side effects of weight loss injections, but could also be signs of liver, bladder, pancreatic or stomach cancer.

She says: “Thyroid swelling or a lump in the neck might be dismissed as an injection side effect, but it could also indicate thyroid cancer.

“The risk of thyroid swelling has been confirmed as a potential side effect by the manufacturers of both Mounjaro and Wegovy.

“And nausea is another common side effect of weight loss jabs that can also indicate liver, bladder or pancreatic cancer.

“There’s a lot of overlap between the symptoms of different organ cancers (like liver and pancreatic cancer) because they affect similar areas of the body.

“This can make identification of cancer symptoms difficult, especially when side effects of weight loss injections are also present.”

It’s also important to note that while use of the jabs results in weight loss, sudden, unexplained, unintentional, and significant (more than 5 per cent of your body weight in six to 12 months) weight loss could be a red flag for cancer.

HOW TO SPOT THE DIFFERENCE

THERE’S not always an easy way to tell the difference between cancer symptoms and weight loss side effects.

It depends on the symptoms you experience, says Ms Goncalves.

She explains: “High levels of acid reflux or heartburn that persist even after you’ve stopped weight loss injections should definitely be looked into by a doctor or GP.

“Also, a lump in the neck, hoarseness, or difficulty swallowing could indicate thyroid cancer.

“It’s not possible to fully tell on your own, so you should consult your doctor or GP if you experience these symptoms.”

WHAT’S THE RISK?

5

KEVIN Joshua, clinical lead at Juniper, an online healthcare provider, says while it’s not very common, confusing symptoms and side effects are a real risk.

He warns: “The danger is that someone may put persistent or worsening symptoms down to the medication, rather than seeing their GP.

“That missed time can make all the difference in cancer treatment and survival.”

Ms Gonclaves adds: “Cancer caught early is far easier to treat. If people assume ongoing pain, nausea or weight loss is just a side effect, they may only get checked once the cancer is more advanced – and that can be life-threatening.

“Given the increasing use of weight loss injections in the UK, the potential for confusion is likely growing, especially for cancer symptoms that overlap with common injection side effects.

“However, there’s currently no large-scale study that estimates how frequently cancer symptoms are misattributed to jabs.

“But it’s important to note the safety of Wegovy and Mounjaro has been proven in clinical trials, and they are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for weight management in the UK.”

WHAT SHOULD YOU DO?

IF you experience any symptoms after starting weight loss jabs, Dr Ogden recommends you do the following:

1. Track your symptoms – keep a daily log noting timing, intensity, and duration.
2. Monitor persistence – common side effects usually settle within two to three weeks.
3. Note severity changes – sudden worsening or new symptoms are red flags.
4. Consult a healthcare professional promptly – don’t wait to see if symptoms pass if they are unusual or severe.
5. Communicate openly – share your symptom log with your GP or specialist for accurate assessment.

Weight loss injections can be safe and effective, but awareness and careful monitoring are essential, added Dr Ogden.

“Early detection of serious issues can save lives and prevent complications.”

The majority of common side effects, such as nausea, diarrhoea, vomiting, skin redness or fatigue, can be managed with adequate hydration, dietary choices, and over‑the‑counter medication.

Ms Goncalves advises: “You can try eating smaller meals, and using herbal teas or oral rehydration salts to alleviate gastrointestinal symptoms.

“You should drink fluids regularly to ensure you are hydrated.”

But you should seek medical help if symptoms are severe, continue for more than a few weeks, or are linked with alarm signs like vomiting blood, blood in stools, jaundice, unexplained weight loss or a lump.

“These should never be written off as ‘just the jab’,” said Mr Joshua.

Indian leader’s remarks follow Trump reaffirming their personal friendship and downplaying his earlier remarks about ‘losing India’ to China.

Indian Prime Minister Narendra Modi says ties with the United States remain “very positive”, after US President Donald Trump reaffirmed their personal friendship and downplayed earlier remarks about “losing India” to China.

“Deeply appreciate and fully reciprocate President Trump’s sentiments and positive assessment of our ties,” Modi said in a statement posted on X on Saturday, adding that India and the US “have a very positive and forward-looking comprehensive and global strategic partnership”.

Strains have emerged between the two longtime allies after the Trump administration imposed tariffs of up to 50 percent on Indian imports, accusing New Delhi of fuelling Moscow’s deadly attacks on Ukraine by purchasing Russian oil.

Speculation of a deepening rift further intensified when Trump remarked on Friday that India, alongside Russia, seems to have been “lost” to China. This came after Modi and Russian President Vladimir Putin met with Chinese President Xi Jinping during a security summit in China.

Earlier this week, Xi hosted more than 20 leaders of non-Western countries – including Modi and Putin – for the Shanghai Cooperation Organisation (SCO) summit in the Chinese port city of Tianjin. It was Modi’s first visit to China in seven years, signalling a thaw between the two Asian powers.

“Looks like we’ve lost India and Russia to deepest, darkest, China. May they have a long and prosperous future together!” Trump wrote in a social media post, with a photo of Modi alongside Xi and Putin.

When asked by reporters later on Friday about his remarks, Trump downplayed his earlier statement, saying he did not think the US had lost India to China.

“I don’t think we have,” he said. “I’ve been very disappointed that India would be buying so much oil, as you know, from Russia. And I let them know that.”

Trump insisted that he “will always be friends with Modi”, adding that “India and the United States have a special relationship“. “There is nothing to worry about,” he said.

Since his first term in office, Trump and Modi, both right-wing populists, have shared a strong bond.

But recently, Trump also appeared irritated at New Delhi as he sought credit for what he said was Nobel Prize-worthy diplomacy for brokering peace between Pakistan and India following the worst conflict in decades between the nuclear-armed neighbours in May.

India, which adamantly rejects any third-party mediation on Kashmir, has since given the cold shoulder to Trump on the matter.

Trump has also been frustrated at his inability to convince Russia and Ukraine to reach an end to their war, more than three years after Russian forces invaded Ukraine.

IT was 1984 and newly qualified doctor Daniel Drucker was excited to dive into the world of ­scientific research.

Fresh out of the University of Toronto Medical School, the 28-year-old was working at a lab in Boston in the US when his supervisor asked him to carry out a routine experiment — which proved to be anything but.

5

5

For it led to Dr Drucker’s discovery of a previously unknown hormone, sparking a new era in medicine.

What he modestly calls a “happy accident” then kick-started a series of ­discoveries that made today’s game-changing weight loss jabs a reality.

The hormone was called glucagon-like peptide 1 — or GLP-1, as the world now knows it.

And the drugs that have resulted from its discovery have produced amazing effects — with users losing up to a fifth of their body weight.

So far around 50,000 of us have been prescribed jabs on the NHS for weight loss, but it is ­estimated around 1.5million people here are buying them privately — a figure that is expected to rise sharply.

Dr Drucker, now 69, tells The Sun: “I never felt like I was on the brink of something huge.

“It was just a fantastic stroke of luck to be in the right place at the right time and to be part of an ­innovation that could improve the health of hundreds of millions of people all over the world.”

The drugs are now being hailed as a possible cure for a range of other conditions too, including dementia and migraine.

But Dr Drucker warns: “We need to be cautious, respect what we don’t know, and not rush into thinking these medicines are right for everyone.

‘Full of hope’

“There could be side-effects we haven’t seen yet, especially in groups we haven’t properly studied.”

Some studies have also raised concerns about gallbladder problems and in rare cases, even ­suicidal thoughts.

GLP-1 was found to play a key role in regulating the appetite and blood sugar levels, by slowing digestion and signalling a feeling of fullness to the brain.

Fat jabs such as Mounjaro and Wegovy contain synthetic versions of GLP-1, tirzepatide and semaglutide, which mimic the natural hormone with astonishing, fat-busting results.

Originally these drugs — known as GLP-1 agonists — were licensed to treat Type 2 diabetes, due to their ability to stimulate the body’s production of insulin, which cuts high blood glucose levels.

But over the past 15 years, after studies ­confirmed the potential to tackle obesity, pharmaceutical firms have reapplied to have the drugs approved as weight loss treatments.

And now evidence is emerging almost daily to suggest these drugs could help treat and even prevent other chronic and degenerative diseases.

Hundreds of scientific trials are under way, and Dr Drucker is “full of hope”, adding that he would consider taking the drugs himself, to ward off ­Alzheimer’s disease.

He says: “I think the next five years is going to be massive. These drugs won’t fix everything, but if they help even half the ­conditions we are testing them for, we could finally find ­treatments for conditions once thought untreatable.”

Decades after his discovery, Dr Drucker is now a professor of ­medicine at the University of Toronto, and a senior investigator at the affiliated Lunenfeld-Tanenbaum Research Institute, where GLP-1 research now fills his life.

He says: “Every morning I turn on my phone and check what’s happened overnight — what new ­discovery has been made, what could this hormone cure or treat.”

Even so, in May UK health chiefs warned that the jabs must not be taken during pregnancy or in the two months before conception, after studies of animals found that semaglutide can cause ­pregnancy loss and birth defects.

But with human use, no such ­danger has been ­confirmed, Dr Drucker says, and dozens of women have ­conceived while taking them.

5

5

Some scientists even believe GLP-1 drugs may boost ­fertility, and could become a go-to for infertility treatment.

Dr Drucker, listed in Time magazine’s 100 Most Influential People in 2024, says: “It wouldn’t surprise me if five years from now, once we have more clinical trial evidence, if we start recommending these medicines to help people get pregnant, and have safer pregnancies.”

It is exciting stuff, but Dr Drucker admits he also worries about people using the drugs for the wrong ­reasons — such as slim, young women in pursuit of unrealistic beauty ideals on social media.

He says: “If I’ve got a 17-year-old who wants to lose another five per cent of her body weight to look like some celebrity, that’s a real concern.

“We haven’t studied 10,000 teenage girls on these drugs over five years. We don’t know how they affect bones, fertility, mental health or development in the long term.”

Last year model Lottie Moss, sister of supermodel Kate, revealed she had ended up in hospital after a seizure linked to high doses of weight loss drug Ozempic.

I think the next five years will be massive. These drugs won’t fix everything, but if they help even half the conditions we are testing for, we could find treatments for conditions thought untreatable

Dr Daniel Drucker

A nurse told her the dose she had been injecting was meant for someone twice her size.

Dr Drucker warned that older adults, people with eating disorders and those with mental health ­conditions may respond differently to the drugs.

He says: “We’re still ­learning, and just because a medicine works well in one group doesn’t mean it is safe for everyone.”

One of the biggest risks is dehydration, which OnlyFans star Lottie blamed for her seizure.

Dr Drucker says: “Some people experience nausea and vomiting, which can lead to dehydration, and that in itself can be dangerous.”
He also warns that losing weight too quickly can reduce muscle mass and bone density, which is especially risky for older people.

He adds: “This is why it is important people only take these drugs when being monitored by medical professionals, so they can be properly assessed for side-effects and receive the safest, most effective care.”

5

So far at least 85 people in the UK have died after taking weight loss jabs, according to reports sent to the Medicines and Healthcare Products Regulatory Agency watchdog.

While none of the deaths has been definitively linked to the drugs, health bodies noted a “suspicion” that they may have played a role.

Dr Drucker says: “Reports like these can raise flags, but without proper comparison groups they don’t tell the full story.

‘Drugs aren’t candy’

“In fact, large trials show GLP-1 drugs actually reduce death rates in people with Type 2 diabetes and those with obesity and heart disease.

“So far, the evidence looks solid and reassuring.”

With millions of patients treated over the years, GLP-1s have a well-established safety record for diabetes and obesity.

But Dr Drucker warns that for newer uses, such as ­Alzheimer’s, fatty liver disease or sleep apnoea, we need more data.

He says: “I don’t think there are any hidden, terrifying side-effects waiting to be uncovered.

“But that doesn’t mean people should take them lightly. We don’t yet have 20 years of experience ­treating some of these ­conditions.

“We need to approach each new indication with appropriate caution, to really understand the benefits ­versus the potential risks.

“These drugs aren’t candy, they won’t fix everything — and like all medicines they have side-effects.

“I don’t think we should abandon our focus on safety. We need to move carefully and thoughtfully as this field evolves.”

I’m not struggling with Type 2 diabetes or obesity, but I do have a family history of ­Alzheimer’s. I’m watching the trials closely and, depending on the results, I wouldn’t rule out taking them in the future

Dr Daniel Drucker

He continues: “I’m not struggling with Type 2 diabetes or obesity, but I do have a family history of ­Alzheimer’s. I’m watching the trials closely and, depending on the results, I wouldn’t rule out taking them in the future.

“I have friends from college who are already showing early signs of cognitive decline, and there’s hope that in some cases, ­semaglutide might help to slow it.”

Several studies over the years ­support that theory.

A recent study by a US university found that the jabs could prevent Alzheimer’s-related changes in people with Type 2 diabetes.

Separate research from Taiwan found that people on GLP-1 agonist drugs appeared to have a 37 per cent lower risk of dementia.

Dr Drucker now regularly receives messages from people around the world whose lives have been changed by the drugs his lab helped to create.

He says: “I get tons of stories. ­People send me emails and photos, not just showing their weight loss, but how their health has changed in other ways too.”

Some say the jabs have helped their chronic pain, cleared brain fog or improved long-standing health conditions such as ulcerative colitis or arthritis.

Dr Drucker adds: “It’s incredibly heartwarming and I never get tired of hearing these stories.”

But for him there is even deeper meaning attached to his discovery.

His 97-year-old mother Cila, ­originally from Poland, survived the Holocaust, spending months as a child hiding in the family’s attic before they were captured and held in a ghetto, where her mother and sister were later shot dead.

At the end of the war in 1945 she became a refugee in Palestine, then in 1953 she emigrated to Canada, first settling in Montreal then making Toronto her home in the 1990s.

Dr Drucker says his work has helped to ease Cila’s survivor’s guilt which had consumed her for decades.

He says: “She looks at my work and she’s so proud of how many people it could potentially help.”

CHICKENPOX has gained a reputation as a ‘harmless’ childhood illness that it’s best to get over with – but it could result in dangerous complications for some and may even prove fatal.

It was announced that children will be given chickenpox vaccines for free on the NHS for the first time from January 2026.

The jab is already used in the US, Canada, Australia and Germany.

One to three-year-olds in the UK will receive the chickenpox vaccine along with the measles, mumps and rubella (MMR) jab.

The combined vaccine will now be dubbed MMRV, as it will protect against the varicella zoster virus.

Responding to news of the chickenpox vaccine rollout in the UK, Dr Gayatri Amirthalingam, from the UK Health Security Agency, said: “For some babies, young children and even adults, chickenpox can be very serious.

“It is excellent news that we will be introducing a vaccine. It could be a lifesaver.”

The news was coupled with warnings from experts that nearly one in five school-starters are not fully protected against preventable diseases – with uptake for the four-in-one diphtheria, tetanus, polio and whooping cough booster and MMR jabs having dropped again.

Chickenpox is a highly contagious infection known for its telltale itchy, spotty rash that blisters and scabs over.

But before these spots appear, the virus can also cause a high temperature, aches and pains, and loss of appetite.

Though it’s mostly known to infect children, adults can also catch chickenpox if they didn’t pick it up in childhood.

These infections tend to be more severe and adults with a varicella infection are more likely to be admitted to hospital.

Most people will recover on their own within a week or two, but the infection can be serious, even life-threatening, for some – especially if they’re very young or old, pregnant or have a weakened immune system.

The illness can result in bacterial skin infections and in rare cases, pneumonia, brain swelling and stroke.

For some, these complications can be fatal.

An average of around 20 people die of chickenpox per year, according to the Vaccine Knowledge Project at the University of Oxford.

This ranges from 17 deaths in 2017, to four in 2020, according to Office for National Statistics data.

Eighty per cent of deaths from chickenpox infections in England and Wales occur in adults, the National Institute for Health and Care Excellence (NICE) states.

1. Bacterial infections

Chickenpox spots can appear anywhere on the body – including inside the mouth and around the genitals.

They tend to develop into fluid-filled blisters, before bursting and scabbing over, which can take a few days.

The spots tend to be maddeningly itchy, so it can be hard to resist the temptation of scratching them – though soothing creams and cool baths can help.

Sometimes the chickenpox spots can get infected with bacteria – probably from scratching, according to healthcare provider Bupa.

Signs of a bacterial infection include a high temperature and redness and pain around the chickenpox spots.

You should seek urgent medical help if you or your child develop these symptoms.

2. Dehydration

Young children do run the risk of becoming dehydrated due to chickenpox.

For babies and kids, fewer wet nappies and peeing less can be telltale signs of dehydration.

Other signs may include:

• Feeling thirsty
• Dark yellow, strong-smelling pee
• Feeling dizzy or lightheaded
• Feeling tired
• A dry mouth, lips and tongue
• Sunken eyes

Call NHS 111 if you suspect you or your little one are dehydrated from chickenpox.

3. Pneumonia

Some people – especially adults – can develop pneumonia, inflammation of the lungs, after being infected with chickenpox.

Pneumonia is the most common chickenpox complication in adults, according to NICE.

Smokers are particularly at risk.

Symptoms of pneumonia can include:

• A cough with yellow or green mucus
• Shortness of breath
• A high temperature
• Chest pain
• An aching body
• Feeling very tired
• Loss of appetite
• Making wheezing noises when you breathe
• Feeling confused

4. Brain swelling

Infection or swelling of the brain, known as encephalitis, is a rare complication of the chickenpox infection.

Professor Benedict Michael, Institute of Infection, University of Liverpool, said: “Varicella-zoster virus is the second leading cause of brain infection (or ‘encephalitis’) in the UK, which can be life-threatening.

“Early diagnosis and treatment are essential, but prevention through vaccination is the most effective way to protect children and families from this serious complication.”

Dr Ava Easton, Chief Executive of Encephalitis International, added: “By making [the chickenpox vaccine] available to every child, we’re not only reducing the spread of chickenpox but also helping to stop some families from ever facing the devastating impact of encephalitis.

“That’s a powerful step forward for children’s health and for awareness of a condition too few people know about.”

Encephalitis usually starts off with flu-like symptoms, such as a high temperature and headache.

More serious symptoms develop in the next few hours, days or weeks, including:

• Confusion or disorientation
• Seizures or fits
• Changes in personality and behaviour
• Difficulty speaking
• Weakness or loss of movement in some parts of the body
• Loss of consciousness

Dial 999 for an ambulance immediately if you or someone else has these serious symptoms.

5. Stroke

According to the Stroke Association, children who develop chickenpox may have a four times higher risk of stroke in the six months following infection.

“However, stroke in children is still rare and the finding translates into a very small actual increase in their stroke risk,” it noted.

Studies by the organisation also found that adults with shingles – also caused by the varicella zoster virus – may also have an increased risk of stroke up until six months afterwards.

“This is particularly within the first few weeks, and for individuals with shingles around the eye,” Stroke Association said.

“Oral antiviral drugs used to treat shingles may be able to reduce this risk.”

6. Sepsis

In rare cases, chickenpox can result in sepsis – when the body’s immune system overreacts to an infection, attacking its own tissues and organs.

Sepsis can be life threatening and requires immediate medical help.

It can also be hard to spot, as there are lots of possible symptoms.

In adults, remember the SEPSIS acronym:

• Slurred speech or confusion
• Extreme shivering or muscle pain
• Passing no urine (in a day)
• Severe breathlessness
• It feels like you’re going to die
• Skin mottled, discoloured, or cold

Other signs include:

• High or very low body temperature
• Rapid heart rate
• Low blood pressure
• Rapid breathing

In children, look out for: 

• Fast breathing
• Lethargy or difficulty waking up
• Mottled, pale, or bluish skin
• Very cold hands and feet
• Seizures
• A rash that doesn’t fade when pressed ,which is a sign of meningococcal sepsis
• Babies not feeding or vomiting 

Getty Images

Who is eligible for Mounjaro from GPs right now?

Will I get Mounjaro if I meet the criteria?

Where else is Mounjaro available?

When can I get Mounjaro if I don’t fit the criteria right now?

What about the rest of the UK?